Cell therapy demand is outpacing manufacturing capacity, forcing clinical supply teams to rethink patient scheduling, production slots, and real-time coordination.
- How Real-World, Real-Time, And Synthetic Data Are Revolutionizing Clinical Trial Supply Chains
- The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains
- Expanding Clinical Trials In Africa Without Disruption
- Bridging Clinical Operations And Supply Chain: Aligning Execution In High-Stakes Trials
- At The Point Of Review: How Clinical Shipments Are Evaluated In Practice
- The cGMP Reality Of Clinical Supply For Advanced Therapies
- How Exit Strategy Should Shape Clinical Trial Supply Planning
- This Assumption Will Break Your Clinical Trial
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Advancing Your API To First Human Dose Trials More Efficiently
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial
Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.
-
Winning The Race To FPI With Early Randomization And Trial Supply Management
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
Capsule Filling Science: Improving Efficiency and Accuracy
Modern trials rely on storage that protects temperature‑sensitive materials. GMP‑ready spaces, monitoring, and flexible capacity help teams manage risk, ensure quality, and keep studies moving.
-
Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Overcome The Supply Chain Complexities Of Vaccine Development
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
Precision and Compliance in Pharmaceutical Packaging
Reliable, compliant packaging preserves product integrity, supports regulatory readiness, and lowers risk. Careful components and controlled processes keep complex therapies protected.
-
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.